Thursday, February 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

New Initiative to Support Studies of the Bat Immune System

by Global Biodefense Staff
April 7, 2021
New Initiative to Support Studies of the Bat Immune System

Photo by Steven Pahel / Unsplash

Understanding the mechanisms of how bats regulate immune responses to clear infections and prevent excessive inflammation may lead to a deeper understanding of the regulatory circuitry of the human immune system and host-pathogen interactions.

The National Institute of Allergy and Infectious Diseases (NIAID) is supporting research to characterize cellular and molecular constituents of the bat immune system to better understand protective innate and adaptive immune mechanisms in bats through a new funding opportunity announcement (FOA) Research on Bat Immunology .

Approximately two-thirds of emerging pathogens are of zoonotic origin, with bats serving as natural reservoir hosts for several RNA viruses that are highly pathogenic to humans, such as severe acute respiratory syndrome-related coronaviruses (SARS-CoVs), Hendra, Marburg, Nipah, and rabies viruses. The bat immune system appears to be uniquely adapted for the control of viral infection without the manifestation of disease or pathology.

This program will support projects to characterize the bat immune system, including defining protective innate or adaptive immune molecules and mechanisms. NIAID’s high-priority areas of interest are:

  • Characterizing the cellular constituents of the bat immune system
  • Dissecting the molecules and pathways involved in regulating the bat’s innate or adaptive immune system
  • Mechanistic studies of bat immunity and resolution of inflammation
  • Studies of the quality, magnitude, and kinetics of bat immune responses during infection
  • Exploring metabolism’s role in bat immune regulation
  • Structural studies of bat immune proteins

Historically, limited reagents have hindered cellular studies with bat primary cells and cell lines. Developing reagents to support bat immunological studies is an allowable research component for applications to this funding opportunity. 

Applications must include a Biohazard Protection and Safety Plan that contains a biohazard risk assessment, and a brief discussion of exposure control and response procedures to protect against possible bat-to-human and human-to-bat transmission events.

The combined budget for direct costs for the two-year project period may not exceed $275,000. Applicants may request no more than $200,000 in direct costs in any single year. Foreign institutions and foreign components are eligible to apply.

The FOA has two receipt dates: July 15, 2021, and March 15, 2022. For inquiries, contact Dr. Kentner Singleton, NIAID’s scientific/research contact.

Tags: Editor PickHendra VirusImmune ResponseNipah VirusOpportunitiesRabiesSARS-CoV-2Zoonotic

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC